Overview

Determination of Remifentanil's ED50 for Rapid Sequence Intubation Avoiding Bradycardia and Hypotension in Adults

Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
This study will find the median effective dose of remifentanil for rapid sequence intubation which avoids bradycardia and hypotension
Phase:
Phase 3
Details
Lead Sponsor:
Brasilia University Hospital
Treatments:
Remifentanil